Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001058:Apomorphine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D008032:Limbic System / Q000201:enzymology; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010395:Penfluridol / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D014150:Antipsychotic Agents; D008781:Methyltyrosines; D011954:Receptors, Dopamine; D010395:Penfluridol; D014446:Tyrosine 3-Monooxygenase; D001058:Apomorphine; D004298:Dopamine